Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Allarity Therapeutics A/S (ST: ALLR)

 
ALLR Technical Analysis
3
As on 20th Dec 2021 ALLR STOCK Price closed @ 1.55 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1.11 & Buy for SHORT-TERM with Stoploss of 1.37 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ALLRSTOCK Price

Open 2.10 Change Price %
High 2.10 1 Day -0.56 -26.54
Low 1.55 1 Week -0.79 -33.76
Close 1.55 1 Month -0.29 -15.76
Volume 2292803 1 Year -0.42 -21.32
52 Week High 3.10 | 52 Week Low 0.64
 
ST Sweden Most Active Stocks
QUIA 0.02 0.00%
QLIFE 0.04 0.00%
SBB-B 5.38 3.07%
STRLNG 0.12 33.33%
LUNE 21.97 6.65%
SAS 0.36 5.88%
URBIT 0.02 0.00%
IDOGEN 0.15 -31.82%
STAR-B 0.89 -1.11%
TELIA 24.60 0.41%
 
ST Sweden Top Gainers Stocks
S2M 0.52 100.00%
NETM-B 1.35 42.11%
STRLNG 0.12 33.33%
IVACC 7.26 32.97%
SPRINT 0.63 16.67%
TH1NG 1.61 16.67%
ATIC 5.14 15.77%
ATIC 5.14 15.77%
CIRCHE 3.69 15.67%
AXIC-A 8.16 15.25%
 
ST Sweden Top Losers Stocks
IDOGEN 0.15 -31.82%
IMMU 0.72 -27.27%
ALLR 1.55 -26.54%
MIDW-A 24.80 -22.98%
KILI 0.76 -16.48%
FRACTL 36.80 -14.02%
DIVIO-B 0.13 -13.33%
ZZ-B 41.50 -12.08%
LIPI 1.49 -11.83%
BACTI-B 72.70 -10.69%
 
 
ALLR
Daily Charts		 ALLR
Intraday Charts		 Whats New @
Bazaartrend		 ALLR
Free Analysis
 
ALLR Important Levels Intraday
RESISTANCE2.61
RESISTANCE2.27
RESISTANCE2.06
RESISTANCE1.85
SUPPORT1.25
SUPPORT1.04
SUPPORT0.83
SUPPORT0.49
 
ALLR Forecast April 2024
Share
4th UP Forecast2.88
3rd UP Forecast2.45
2nd UP Forecast2.19
1st UP Forecast1.93
1st DOWN Forecast1.17
2nd DOWN Forecast0.91
3rd DOWN Forecast0.65
4th DOWN Forecast0.22
 
ALLR Weekly Forecast
4th UP Forecast2.07
3rd UP Forecast1.90
2nd UP Forecast1.80
1st UP Forecast1.70
1st DOWN Forecast1.40
2nd DOWN Forecast1.30
3rd DOWN Forecast1.20
4th DOWN Forecast1.03
 
ALLR Forecast2024
4th UP Forecast7.18
3rd UP Forecast5.37
2nd UP Forecast4.26
1st UP Forecast3.14
1st DOWN Forecast-0.04
2nd DOWN Forecast-1.16
3rd DOWN Forecast-2.27
4th DOWN Forecast-4.08
 
 
ALLR Other Details
Segment EQ
Market Capital 609320640.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ALLR Address
ALLR
 
ALLR Latest News
 
Your Comments and Response on Allarity Therapeutics A/S
 
ALLR Business Profile
Allarity Therapeutics A/S develops various therapeutic candidates for the treatment of cancer using drug-specific companion diagnostics (cDx) generated by its drug response predictor technology. Its lead therapeutic candidate is dovitinib, a second-generation pan-tyrosine kinase inhibitor with the ability to inhibit numerous classes of tumor-driving tyrosine kinases, including FGFR, VEGFR, PDGFR, c-Kit, Flt-3, and CSF-1. The company's therapeutic candidates also include stenoparib, selective inhibitor of the key DNA damage repair enzyme poly-ADP-ribose polymerase; and IXEMPRA, a selective microtubule inhibitor that interferes with cancer cell division through mitotic arrest. It also developing other therapeutic candidates comprising LiPlaCis, a targeted liposomal formulation of Cisplatin; 2X-111, a targeted liposomal formulation of Doxorubicin; and Irofulven, a DNA damaging agent. The company was founded in 2004 and is headquartered in Horsholm, Denmark. Address: Venlighedsvej 1, Horsholm, Denmark, 2970
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service